Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease.

Zuern C, Krenacs L, Starke S, Heimrich J, Palmetshofer A, Holtmann B, Sendtner M, Fischer T, Galle J, Wanner C, Seibold S.

Int J Oncol. 2012 Apr;40(4):1079-88. doi: 10.3892/ijo.2011.1311. Epub 2011 Dec 20.

2.

Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.

Akimzhanov A, Krenacs L, Schlegel T, Klein-Hessling S, Bagdi E, Stelkovics E, Kondo E, Chuvpilo S, Wilke P, Avots A, Gattenlöhner S, Müller-Hermelink HK, Palmetshofer A, Serfling E.

Am J Pathol. 2008 Jan;172(1):215-24. Epub 2007 Dec 21.

3.

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E.

J Exp Med. 2007 Jun 11;204(6):1303-10. Epub 2007 May 14.

4.

Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines.

Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Tertilt C, Bopp T, Heib V, Becker M, Taube C, Schild H, Schmitt E, Stassen M.

J Immunol. 2006 Nov 15;177(10):6667-74.

5.

NFAT transcription factors in control of peripheral T cell tolerance.

Serfling E, Klein-Hessling S, Palmetshofer A, Bopp T, Stassen M, Schmitt E.

Eur J Immunol. 2006 Nov;36(11):2837-43. Review.

6.

NFATc1 autoregulation: a crucial step for cell-fate determination.

Serfling E, Chuvpilo S, Liu J, Höfer T, Palmetshofer A.

Trends Immunol. 2006 Oct;27(10):461-9. Epub 2006 Aug 22.

PMID:
16931157
7.

Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.

Trujillo-Vargas CM, Mayer KD, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda JR, Polte T, Hansen G, Wohlleben G, Erb KJ.

Clin Exp Allergy. 2005 Aug;35(8):1003-13.

PMID:
16120081
8.

A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.

Glud SZ, Sørensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenacs L, Stelkovics E, Wabl M, Serfling E, Palmetshofer A, Pedersen FS.

Blood. 2005 Nov 15;106(10):3546-52. Epub 2005 Jul 28.

9.

Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.

Trujillo-Vargas CM, Ramirez-Pineda JR, Palmetshofer A, Grunewald S, Moll H, Berberich C, Erb KJ.

Int Arch Allergy Immunol. 2005 Jul;137(3):219-28. Epub 2005 Jun 13.

PMID:
15956790
10.

Pim-1 kinase enhances NFATc activity and neuroendocrine functions in PC12 cells.

Glazova M, Aho TL, Palmetshofer A, Murashov A, Scheinin M, Koskinen PJ.

Brain Res Mol Brain Res. 2005 Aug 18;138(2):116-23.

PMID:
15935514
11.

B cell hyperresponsiveness and expansion of mature follicular B cells but not of marginal zone B cells in NFATc2/c3 double-deficient mice.

Samanta DN, Palmetshofer A, Marinkovic D, Wirth T, Serfling E, Nitschke L.

J Immunol. 2005 Apr 15;174(8):4797-802.

12.

NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.

Bopp T, Palmetshofer A, Serfling E, Heib V, Schmitt S, Richter C, Klein M, Schild H, Schmitt E, Stassen M.

J Exp Med. 2005 Jan 17;201(2):181-7.

13.

NFAT and NF-kappaB factors-the distant relatives.

Serfling E, Berberich-Siebelt F, Avots A, Chuvpilo S, Klein-Hessling S, Jha MK, Kondo E, Pagel P, Schulze-Luehrmann J, Palmetshofer A.

Int J Biochem Cell Biol. 2004 Jul;36(7):1166-70. Review.

PMID:
15109564
15.

cGMP-dependent protein kinase type II regulates basal level of aldosterone production by zona glomerulosa cells without increasing expression of the steroidogenic acute regulatory protein gene.

Gambaryan S, Butt E, Marcus K, Glazova M, Palmetshofer A, Guillon G, Smolenski A.

J Biol Chem. 2003 Aug 8;278(32):29640-8. Epub 2003 May 29.

16.

Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation.

Diehl S, Chow CW, Weiss L, Palmetshofer A, Twardzik T, Rounds L, Serfling E, Davis RJ, Anguita J, Rincón M.

J Exp Med. 2002 Jul 1;196(1):39-49.

17.

Inhibition of cGMP-dependent protein kinase II by its own splice isoform.

Gambaryan S, Palmetshofer A, Glazova M, Smolenski A, Kristjansson GI, Zimmer M, Lohmann SM.

Biochem Biophys Res Commun. 2002 May 24;293(5):1438-44.

PMID:
12054676
18.

A cGMP-dependent protein kinase assay for high throughput screening based on time-resolved fluorescence resonance energy transfer.

Bader B, Butt E, Palmetshofer A, Walter U, Jarchau T, Drueckes P.

J Biomol Screen. 2001 Aug;6(4):255-64.

PMID:
11689125
19.

Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells.

Heermeier K, Leicht W, Palmetshofer A, Ullrich M, Wanner C, Galle J.

J Am Soc Nephrol. 2001 Mar;12(3):456-63.

20.

Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells.

Fischer TA, Palmetshofer A, Gambaryan S, Butt E, Jassoy C, Walter U, Sopper S, Lohmann SM.

J Biol Chem. 2001 Feb 23;276(8):5967-74. Epub 2000 Nov 9.

21.

KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.

Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A.

J Biol Chem. 2000 Oct 27;275(43):33536-41.

22.
23.

Tyrosine phosphorylation following lectin mediated endothelial cell stimulation.

Palmetshofer A, Robson SC, Bach FH.

Xenotransplantation. 1998 Feb;5(1):61-6.

PMID:
9507735
25.

Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis.

von Albertini M, Palmetshofer A, Kaczmarek E, Koziak K, Stroka D, Grey ST, Stuhlmeier KM, Robson SC.

Biochem Biophys Res Commun. 1998 Jul 30;248(3):822-9.

PMID:
9704012
26.

Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation.

Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH.

Transplantation. 1998 Apr 15;65(7):971-8.

PMID:
9565103
27.

Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF.

Anrather D, Millan MT, Palmetshofer A, Robson SC, Geczy C, Ritchie AJ, Bach FH, Ewenstein BM.

J Immunol. 1997 Dec 1;159(11):5620-8.

PMID:
9548505
28.

Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation.

Palmetshofer A, Galili U, Dalmasso AP, Robson SC, Bach FH.

Transplantation. 1998 Mar 27;65(6):844-53.

PMID:
9539098
29.

Prevalence of polyclonal gammopathy in polyneuropathy.

Gorson KC, Ropper AH, Palmetshofer AK, Weinstein R.

Neurology. 1997 Dec;49(6):1747. No abstract available.

PMID:
9409386
30.

A20 expression inhibits endothelial cell activation.

Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C.

Transplant Proc. 1997 Feb-Mar;29(1-2):881. No abstract available.

PMID:
9123565
31.

A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.

Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C.

J Biol Chem. 1996 Jul 26;271(30):18068-73.

32.

Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts.

Palmetshofer A, Zechner D, Luger TA, Barta A.

Mol Cell Endocrinol. 1995 Sep 22;113(2):225-34.

PMID:
8674830
33.

From RNA to sequenced clones within three days: a complete protocol.

Simon MM, Palmetshofer A, Schwarz T.

Biotechniques. 1994 Apr;16(4):633-6, 638.

PMID:
7517686

Supplemental Content

Loading ...
Support Center